January 25, 2023
Video
Nathan Pennell, MD, PhD, discusses the importance of developing drugs based on resistance to previous treatments in patients with non–small cell lung cancer.
September 16, 2022
Video
Nathan A. Pennell, MD, PhD, discusses the importance of developing new RET inhibitors for patients with non–small cell lung cancer.
July 09, 2022
Video
Nathan A. Pennell, MD, PhD, discusses the study design and goals of an ongoing phase 1 trial of a novel RET inhibitor for patients with non–small cell lung cancer and medullary thyroid cancer.
June 15, 2022
Video
Nathan Pennell, MD, PhD, discusses a first-in-human trial of a novel RET inhibitor for patients with non–small cell lung cancer and medullary thyroid cancer.
April 03, 2020
Video
Nathan A. Pennell, MD, PhD, discusses the role of molecular testing when treating and managing patients with lung cancer. He shares his advice on what to do for patients who need therapy immediately, as well.